Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.

导出 OA

翻译打印收藏纠错

作者： Matthew B,Laurens ^[1] ; Randy G,Mungwira ^[2] ; Nginache,Nampota ^[2] ; Osward M,Nyirenda ^[2] ; Titus H,Divala ^[2] ; Maxwell,Kanjala ^[2] ; Felix A,Mkandawire ^[2] ; Lufina Tsirizani,Galileya ^[2] ; Wongani,Nyangulu ^[3] ; Edson,Mwinjiwa ^[3] ; Matthew,Downs ^[4] ; Amy,Tillman ^[4] ; Terrie E,Taylor ^[2] ; Jane,Mallewa ^[5] ; Christopher V,Plowe ^[2] ; Joep J,van Oosterhout ^[1] ; Miriam K,Laufer ^[6]

作者单位： Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA. ^[1] Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi. ^[2] Dignitas International, Zomba, Malawi. ^[3] Statistics Collaborative, Washington, DC, USA. ^[4] College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA. ^[5] Dignitas International and University of Malawi College of Medicine, Blantyre, Malawi. ^[6]

关键词 Africa HIV infection chloroquine malaria trimethoprim-sulfamethoxazole

主题词成年人(Adult);抗逆转录病毒药(Anti-Retroviral Agents);CD4淋巴细胞计数(CD4 Lymphocyte Count);HIV感染(HIV Infections);人类(Humans);马拉维(Malawi)

DOI 10.1093/cid/ciab252

PMID 33744963

发布时间 2023-06-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交